Skip to main content
Erschienen in: American Journal of Clinical Dermatology 2/2000

01.03.2000 | Disease Management

α-Hydroxy Acid-Based Cosmetic Procedures

Guidelines For Patient Management

verfasst von: Rebecca C. Tung, Dr Wilma F. Bergfeld, Allison T. Vidimos, Berna K. Remzi

Erschienen in: American Journal of Clinical Dermatology | Ausgabe 2/2000

Einloggen, um Zugang zu erhalten

Abstract

α-Hydroxy acid (AHA) peels and home regimens have recently been recognized as important adjunctive therapy in a variety of conditions including photodamage, actinic damage, melasma, hyperpigmentation disorders, acne, and rosacea. Overall in our experience and in the literature, AHAs have a proven level of safety and efficacy in a variety of skin types. Although their exact mechanism of action is unknown, it has been demonstrated that AHAs improve these disorders by thinning the stratum corneum, promoting epidermolysis, dispersing basal layer melanin, and increasing collagen synthesis within the dermis.
In patients with photodamage, AHA peels and topical products are often combined with retinoids and other antioxidants for maximum benefit. Similarly, synergistic effects of fluorouracil and glycolic acid are observed in the treatment of diffuse actinic keratoses. For patients with melasma, AHA peels and combination products containing bleaching agents such as hydroquinone, kojic acid, and glycolic acid seem to have increased efficacy. Acne and rosacea patients can see improved results when standard regimens like antibacterials and topical retinoids are supplemented with AHA peels and lotions.
However, care should always be taken prior to commencing treatment with AHA peels and topical products. By obtaining a thorough history and physical examination, the physician will identify any specific factors like medications, prior procedures and medical conditions which can affect the outcome of the peel. During the interview, there should be open discussion of patient questions and concerns so that realistic expectations can be made. Pre- and post-peel regimens should also be reviewed in full as patient compliance is essential to ensure the success of a series of AHA peels.
Literatur
1.
Zurück zum Zitat Van Scott E.J., Liu R.J. Alpha hydroxy acids: procedures for use in clinical practice. Cutis 1989; 43: 222–228PubMed Van Scott E.J., Liu R.J. Alpha hydroxy acids: procedures for use in clinical practice. Cutis 1989; 43: 222–228PubMed
2.
Zurück zum Zitat Bergfeld W., Tung R., Vidimos A., et al. Improving the appearance of photoaged skin with glycolic acid. J Am Acad Dermatol 1997; 36: 1011–1013PubMedCrossRef Bergfeld W., Tung R., Vidimos A., et al. Improving the appearance of photoaged skin with glycolic acid. J Am Acad Dermatol 1997; 36: 1011–1013PubMedCrossRef
3.
Zurück zum Zitat Stiller N.J., Bartolone, Stern R., et al. Topical 8% glycolic acid and 8% L-lactic acid creams for the treatment of photoaged skin. Arch Dermatol 1996; 132: 631–635PubMedCrossRef Stiller N.J., Bartolone, Stern R., et al. Topical 8% glycolic acid and 8% L-lactic acid creams for the treatment of photoaged skin. Arch Dermatol 1996; 132: 631–635PubMedCrossRef
4.
Zurück zum Zitat Perricone N.V., Dinardo J.C. Photoprotective and anti-inflammatory effects of topical glycolic acid. Dermatol Surg 1996; 22: 435–437PubMedCrossRef Perricone N.V., Dinardo J.C. Photoprotective and anti-inflammatory effects of topical glycolic acid. Dermatol Surg 1996; 22: 435–437PubMedCrossRef
5.
Zurück zum Zitat Clark C.P. Alpha hydroxy acids in skin care. Clin Plast Surg 1996; 23: 49–56PubMed Clark C.P. Alpha hydroxy acids in skin care. Clin Plast Surg 1996; 23: 49–56PubMed
6.
Zurück zum Zitat Dinardo J.C., Grove G.L., Moy L.S.. Clinical and histological effects of glycolic acid at different concentrations and pH levels. Dermatol Surg 1996; 22: 421–424PubMedCrossRef Dinardo J.C., Grove G.L., Moy L.S.. Clinical and histological effects of glycolic acid at different concentrations and pH levels. Dermatol Surg 1996; 22: 421–424PubMedCrossRef
7.
Zurück zum Zitat Maddin S. Current review of alpha hydroxy acids. Skin Ther Lett 1998; 3: 1–2 Maddin S. Current review of alpha hydroxy acids. Skin Ther Lett 1998; 3: 1–2
8.
Zurück zum Zitat Moy L.S., Howe K., Moy R.L.. Glycolic acid modulation of collagen production in human skin fibroblast cultures in vitro. Dermatol Surg 1996; 22: 439–441PubMedCrossRef Moy L.S., Howe K., Moy R.L.. Glycolic acid modulation of collagen production in human skin fibroblast cultures in vitro. Dermatol Surg 1996; 22: 439–441PubMedCrossRef
9.
Zurück zum Zitat Kim S.J., Park J.H., Kim D.H., et al. Increased in vivo collagen synthesis and in vitro cell collagen synthesis and in vitro cell proliferative effect of glycolic acid. Dermatol Surg 1998; 24: 1054–1058PubMedCrossRef Kim S.J., Park J.H., Kim D.H., et al. Increased in vivo collagen synthesis and in vitro cell collagen synthesis and in vitro cell proliferative effect of glycolic acid. Dermatol Surg 1998; 24: 1054–1058PubMedCrossRef
10.
Zurück zum Zitat Matarasso S.L., Hanke C.W., Alster T.S.. Cutaneous resurfacing. Dermatol Clin 1997; 135: 867–875 Matarasso S.L., Hanke C.W., Alster T.S.. Cutaneous resurfacing. Dermatol Clin 1997; 135: 867–875
11.
Zurück zum Zitat Gilchrist B.A. A review of skin ageing and its medical therapy. Br J Dermatol 1996; 135: 867–875CrossRef Gilchrist B.A. A review of skin ageing and its medical therapy. Br J Dermatol 1996; 135: 867–875CrossRef
12.
Zurück zum Zitat Lewis A.B., Gendler E.C.. Resurfacing with topical agents. Semin Cutan Med Surg 1996; 15: 139–144PubMedCrossRef Lewis A.B., Gendler E.C.. Resurfacing with topical agents. Semin Cutan Med Surg 1996; 15: 139–144PubMedCrossRef
13.
Zurück zum Zitat Newman N., Newman A., Moy L.S., et al. Clinical improvement of photoaged skin with 50% glycolic acid. Dermatol Surg 1996; 22: 455–460PubMedCrossRef Newman N., Newman A., Moy L.S., et al. Clinical improvement of photoaged skin with 50% glycolic acid. Dermatol Surg 1996; 22: 455–460PubMedCrossRef
14.
Zurück zum Zitat Murad H.,. Shamban A.T., Premo P.S. The use of glycolic acid as a peeling agent. Dermatol Clin 1995; 13: 285–307PubMed Murad H.,. Shamban A.T., Premo P.S. The use of glycolic acid as a peeling agent. Dermatol Clin 1995; 13: 285–307PubMed
15.
Zurück zum Zitat Huilgol S.C., Carruthers A.,. Caruthers J.D. Raising eyebrows with botulinum toxin. Dermatol Surg 1999; 25: 373–375PubMedCrossRef Huilgol S.C., Carruthers A.,. Caruthers J.D. Raising eyebrows with botulinum toxin. Dermatol Surg 1999; 25: 373–375PubMedCrossRef
16.
Zurück zum Zitat Klein A.W., Wexler P.,. Carruthers A.,. et al. Treatment of facial furrows and rhytides. Dermatol Clin 1997; 15: 595–607PubMedCrossRef Klein A.W., Wexler P.,. Carruthers A.,. et al. Treatment of facial furrows and rhytides. Dermatol Clin 1997; 15: 595–607PubMedCrossRef
17.
Zurück zum Zitat Bolognia J.L. Dermatologic and cosmetic concerns of the older woman. Clin Geriatr Med 1993; 9: 209–229PubMed Bolognia J.L. Dermatologic and cosmetic concerns of the older woman. Clin Geriatr Med 1993; 9: 209–229PubMed
18.
Zurück zum Zitat Marks R. Solar keratoses. Br J Dermatol 190; 122 Suppl. 35: 49-60 Marks R. Solar keratoses. Br J Dermatol 190; 122 Suppl. 35: 49-60
19.
20.
Zurück zum Zitat Winton G.B., Lewis C.W. Dermatoses of pregnancy. J Am Acad Dermatol 1982; 66: 977–998CrossRef Winton G.B., Lewis C.W. Dermatoses of pregnancy. J Am Acad Dermatol 1982; 66: 977–998CrossRef
21.
Zurück zum Zitat Garcia A.,. Fulton J.E. The combination of glycolic acid and hydroquinone or kojic acid for the treatment of melasma and related conditions. Dermatol Surg 1996; 22: 443–447PubMedCrossRef Garcia A.,. Fulton J.E. The combination of glycolic acid and hydroquinone or kojic acid for the treatment of melasma and related conditions. Dermatol Surg 1996; 22: 443–447PubMedCrossRef
22.
Zurück zum Zitat Lim J.T.E., Tham S.N. Glycolic acid peels in the treatment of melasma among asian women. Dermatol Surg 1997; 23: 177–179PubMedCrossRef Lim J.T.E., Tham S.N. Glycolic acid peels in the treatment of melasma among asian women. Dermatol Surg 1997; 23: 177–179PubMedCrossRef
23.
Zurück zum Zitat Van Scott E.J., Yu R.J. Alpha hydroxy acids: therapeutic potentials. Can J Dermatol1989; 1: 108–112 Van Scott E.J., Yu R.J. Alpha hydroxy acids: therapeutic potentials. Can J Dermatol1989; 1: 108–112
25.
Zurück zum Zitat Goulden V.,. Clark S.M., Cunliffe W.J. Post-adolescent acne: review of clinical features.Br J Dermatol 1997; 136: 66–70PubMedCrossRef Goulden V.,. Clark S.M., Cunliffe W.J. Post-adolescent acne: review of clinical features.Br J Dermatol 1997; 136: 66–70PubMedCrossRef
26.
Zurück zum Zitat Sperling L.,. Hermer W. Androgen biology as a basis for the diagnosis and treatment of androgenic disorders in women. J Am Acad Dermatol 1993; 28: 669–683PubMedCrossRef Sperling L.,. Hermer W. Androgen biology as a basis for the diagnosis and treatment of androgenic disorders in women. J Am Acad Dermatol 1993; 28: 669–683PubMedCrossRef
27.
28.
Zurück zum Zitat Lucky A.W., Henderson T.A., Olson W.H., et al. Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris. J Am Acad Dermatol. 1997; 37: 746–754PubMedCrossRef Lucky A.W., Henderson T.A., Olson W.H., et al. Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris. J Am Acad Dermatol. 1997; 37: 746–754PubMedCrossRef
29.
Zurück zum Zitat Plewig G., Jansen T. Rosacea. In: Freedberg I.M., Eisen A.Z., Wolff K., et al., editors. Fitzpatrick’s dermatology in general medicine. New York: McGraw-Hill, 1999: 785–794 Plewig G., Jansen T. Rosacea. In: Freedberg I.M., Eisen A.Z., Wolff K., et al., editors. Fitzpatrick’s dermatology in general medicine. New York: McGraw-Hill, 1999: 785–794
30.
Zurück zum Zitat Bonnar E.,. Eustace P., Powell FC. Demodex mite population in rosacea. J Am Acad Dermatol 1993; 28: 443–448PubMedCrossRef Bonnar E.,. Eustace P., Powell FC. Demodex mite population in rosacea. J Am Acad Dermatol 1993; 28: 443–448PubMedCrossRef
31.
Zurück zum Zitat Utas U.,. Ozbakin O.,. Turasan A., et al. Helicobacter pylori eradication treatment reduces severity of rosacea. J Am Acad Dermatol 1999; 40: 433–435PubMedCrossRef Utas U.,. Ozbakin O.,. Turasan A., et al. Helicobacter pylori eradication treatment reduces severity of rosacea. J Am Acad Dermatol 1999; 40: 433–435PubMedCrossRef
32.
Zurück zum Zitat Bergfeld W.F., Remzi B.K., Green B., et al. Evaluation of gluconolactone sensitive skin care products [poster]. American Academy of Dermatology Meeting. 1998; Orlando (FL) Bergfeld W.F., Remzi B.K., Green B., et al. Evaluation of gluconolactone sensitive skin care products [poster]. American Academy of Dermatology Meeting. 1998; Orlando (FL)
33.
Zurück zum Zitat Dahl M.V. Optimal strategies for the treatment of rosacea. Skin Aging 1999; 7: 44–48 Dahl M.V. Optimal strategies for the treatment of rosacea. Skin Aging 1999; 7: 44–48
34.
Zurück zum Zitat Wang C.-M., Huang C.-L., Hu C.-T.S., et al. The effect of glycolic acid on the treatment of acne in asian skin. Dermatol Surg 1997; 23: 23–29PubMedCrossRef Wang C.-M., Huang C.-L., Hu C.-T.S., et al. The effect of glycolic acid on the treatment of acne in asian skin. Dermatol Surg 1997; 23: 23–29PubMedCrossRef
35.
Zurück zum Zitat Duffy D.M. Alpha hydroxy acids / trichloroacetic acids risk / benefit strategies.Dermatol Surg 1998; 24: 181–189PubMedCrossRef Duffy D.M. Alpha hydroxy acids / trichloroacetic acids risk / benefit strategies.Dermatol Surg 1998; 24: 181–189PubMedCrossRef
36.
Zurück zum Zitat Slavin J.W. Considerations in alpha hydroxy acid peels. Clin Plast Surg 1998; 25: 45–52PubMed Slavin J.W. Considerations in alpha hydroxy acid peels. Clin Plast Surg 1998; 25: 45–52PubMed
37.
Zurück zum Zitat Kripke M. Ozone, photodamage, and photoprotection. Presented at the American Academy of Dermatology. 1998 Jul 31; Chicago (IL) Kripke M. Ozone, photodamage, and photoprotection. Presented at the American Academy of Dermatology. 1998 Jul 31; Chicago (IL)
38.
39.
Zurück zum Zitat Naylor M.F., Boyd A., Smith D.W., et al. High sun protection factor sunscreens in suppresion of actinic neoplasia. Arch Dermatol 1995; 131: 170–175PubMedCrossRef Naylor M.F., Boyd A., Smith D.W., et al. High sun protection factor sunscreens in suppresion of actinic neoplasia. Arch Dermatol 1995; 131: 170–175PubMedCrossRef
40.
Zurück zum Zitat Bergfeld W.F., Fiume M.Z., Andersen F.A. Safety assessment of alpha hydroxy acid ingredients used in cosmetic products. Cleveland (OH): Cleveland Clinic Foundation, 1999 Bergfeld W.F., Fiume M.Z., Andersen F.A. Safety assessment of alpha hydroxy acid ingredients used in cosmetic products. Cleveland (OH): Cleveland Clinic Foundation, 1999
Metadaten
Titel
α-Hydroxy Acid-Based Cosmetic Procedures
Guidelines For Patient Management
verfasst von
Rebecca C. Tung
Dr Wilma F. Bergfeld
Allison T. Vidimos
Berna K. Remzi
Publikationsdatum
01.03.2000
Verlag
Springer International Publishing
Erschienen in
American Journal of Clinical Dermatology / Ausgabe 2/2000
Print ISSN: 1175-0561
Elektronische ISSN: 1179-1888
DOI
https://doi.org/10.2165/00128071-200001020-00002

Weitere Artikel der Ausgabe 2/2000

American Journal of Clinical Dermatology 2/2000 Zur Ausgabe

Adis New Drug Profile

Topical Aminolevulinic Acid HCl

Disease Management

Management of Hirsutism

Adis New Drug Profile

Topical Aminolevulinic Acid HCL

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Kein Abstrich bei chronischen Wunden ohne Entzündungszeichen!

16.04.2024 DGIM 2024 Nachrichten

Den Reflex, eine oberflächliche chronische Hautwunde ohne Entzündungszeichen in jedem Fall abzustreichen, sollte man nach einer neuen „Klug-entscheiden“-Empfehlung unterdrücken.

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.